作　　者： ; ; ; ;

机构地区： 南方医科大学

出　　处： 《分子影像学杂志》 2019年第3期297-300,共4页

摘　　要： 目的探讨早期显微手术切除出血性脑动静脉畸形的安全性和有效性。方法对2015年1月~2019年4月收治的46例经CTA和(或)DSA证实为脑动静脉畸形的患者资料进行回顾性分析。结果46例脑脑动静脉畸形(AVM)患者中,86.9%(40/46)的患者获得全部切除,26例出院时恢复良好,轻残13例,重残5例,死亡2例。高级别脑动静脉畸形(AVM)、血肿量>50mL、幕下动静脉畸形患者预后较差。结论早期显微手术治疗出血性AVM,特别是低、中级别脑AVM是安全有效的,其能够快速降低颅内压,全切畸形团,预防再出血,同时保留神经功能,促进患者更加快速及时的康复。 Objective To explore the safety and effectiveness of early microsurgical removal of bleeding arteriovenous malformations. Methods The clinical data of 46 patients with AVM by early microsurgical treatment in our hospital from January 2015 to April 2019 were retrospectively reviewed in the acute stage of bleeding(within the first week after bleed). All patients showed a cerebral AVM on DSA or CTA at admission. Results In the 46 patients, total resection was achieved in 40 cases(86.9%, 40/46). A favorable functional outcome was observed in 26 patients, 13 cases were mild disability, 5 cases were severe disability, and 2 patients died. The patients with high Spetzler-Martin(SM)grade, volume hematoma larger than 50 ml, AVM located in cerebellar resulted in poor outcomes. Conclusion Early microsurgery for bleeding AVMs is a safe and definitive treatment. It achieves both immediate cerebral decompression and protection against rebreeding, resects cerebral AVMs totally, avoids neurologic comprimise and allows a more rapid rehabilitative course whenever necessary.

关 键 词： 脑动静脉畸形 早期显微外科技术 分级

领　　域： []